Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR

Francesco Berlanda Scorza1, Francesco Doro, Manuel José Rodríguez-Ortega

  • 1Biochemistry and Molecular Biology Unit, Novartis Vaccines and Diagnostics, 53100 Siena, Italy.

Insights

Researchers identified 100 outer membrane proteins from pathogenic Escherichia coli, including seven specific to pathogenic strains, offering new targets for vaccines and therapies against bacterial infections.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Proteomics

Background:

  • Extraintestinal pathogenic Escherichia coli cause severe human and animal infections.
  • Outer membrane proteins are crucial for bacterial function and potential therapeutic targets.

Purpose of the Study:

  • To identify outer membrane proteins of pathogenic E. coli.
  • To explore their potential as targets for vaccines and therapeutics.

Main Methods:

  • Generated a DeltatolR mutant of E. coli IHE3034 to enhance outer membrane vesicle (OMV) release.
  • Analyzed OMVs using 2D electrophoresis and mass spectrometry.

Main Results:

  • Identified 100 proteins in OMVs, primarily from outer membrane and periplasmic compartments.
  • Discovered seven OMV proteins specific to pathogenic E. coli and enteric bacteria.
  • Confirmed the association of cytolethal distending toxin with OMVs, suggesting a role in toxin delivery.

Conclusions:

  • OMVs are valuable tools for studying Gram-negative bacterial outer membrane and periplasm.
  • Identified pathogenic E. coli-specific proteins represent promising targets for novel vaccines and drugs.
  • Bacterial vesicles play a role in delivering toxins to host cells, advancing understanding of pathogenesis.